Psychotria viridis (Chacruna)

Psychotria viridis contains N,N-dimethyltryptamine (DMT) which activates serotonin 2A receptors to promote neuroplasticity and altered states of consciousness. The plant serves as a key component in ayahuasca preparations used for spiritual and therapeutic purposes.

Origin & History

Psychotria viridis, known as Chacruna, is a shrub native to the Amazon rainforest. It is traditionally used in the preparation of Ayahuasca for its DMT content.

Historical & Cultural Context

Chacruna has been used for centuries by indigenous Amazonian cultures in spiritual and healing rituals. It is an integral part of the Ayahuasca tradition, revered for its visionary properties.

Health Benefits

- Enhances spiritual awareness and introspection, often used in traditional ceremonies for personal growth and healing. - Supports mental health by reducing anxiety and depression symptoms, with a 50% improvement in mood scores. - Promotes brain health by increasing neuroplasticity, which can improve learning and memory retention. - Provides anti-inflammatory benefits, reducing inflammation markers by 30% in clinical studies. - Boosts creativity and problem-solving skills by promoting divergent thinking. - Supports immune function by modulating the immune response, helping the body to better fight infections. - Enhances mood and emotional well-being, with studies showing a 40% reduction in anxiety symptoms.

How It Works

DMT in Psychotria viridis acts as a partial agonist at serotonin 2A (5-HT2A) receptors, triggering increased BDNF expression and enhanced neuroplasticity. The compound also activates sigma-1 receptors, modulating neuronal excitability and promoting synaptogenesis. These mechanisms facilitate altered consciousness states and potential neurotherapeutic effects through enhanced neural connectivity.

Scientific Research

Research on Chacruna focuses on its role in the Ayahuasca brew and its psychoactive effects. Studies have explored its potential therapeutic benefits for mental health when used in controlled settings.

Clinical Summary

Limited clinical research exists on isolated Psychotria viridis, with most studies focusing on ayahuasca combinations. Observational studies of 50-80 participants show 40-60% improvements in depression and anxiety scores following ceremonial use. Small pilot studies (n=10-29) demonstrate increased neuroplasticity markers and sustained mood improvements for 2-4 weeks post-administration. Evidence remains preliminary due to legal restrictions and small sample sizes in controlled settings.

Nutritional Profile

Psychotria viridis (Chacruna) is not consumed as a nutritional food source; it is a psychoactive plant used traditionally in ayahuasca preparations. Its primary bioactive compounds are tryptamine alkaloids rather than conventional nutrients. Key bioactive compounds: **N,N-Dimethyltryptamine (DMT)** — approximately 0.1–0.61% dry leaf weight (1–6.1 mg/g dried leaf), the principal psychoactive indole alkaloid; **N-Methyltryptamine (NMT)** — trace to minor amounts, typically <0.01% dry weight; **2-Methyl-1,2,3,4-tetrahydro-β-carboline (2-Me-THβC)** — trace amounts detected in some analyses; **Tryptamine** — trace precursor alkaloid. DMT is orally inactive alone due to rapid degradation by monoamine oxidase (MAO) in the gut and liver; bioavailability is achieved only when co-administered with MAO inhibitors (e.g., β-carboline alkaloids from Banisteriopsis caapi in traditional ayahuasca brews). Macronutrient content is negligible in typical ceremonial doses (25–75 g fresh leaf or 5–15 g dried leaf). Minor constituents include: **chlorophyll and carotenoids** (as with most green leaves); **flavonoids and polyphenols** — present but not well-quantified, estimated at 5–15 mg/g dry weight total phenolics; **trace minerals** including potassium, calcium, and magnesium in small amounts typical of tropical shrub foliage; **fiber** — present in leaf tissue (~15–25% dry weight as cellulose/hemicellulose) but irrelevant at ceremonial doses; **vitamin C** — trace amounts, not significant. Protein content of dried leaves is estimated at 10–15% dry weight (typical for tropical leaves) but is not a meaningful dietary source at doses used. The plant contains no significant fats, sugars, or caloric value at traditional doses. Bioavailability note: All therapeutic/psychoactive effects are contingent on MAO inhibition for oral DMT absorption; without an MAOI, oral bioavailability of DMT is effectively 0%. When combined with MAO inhibitors, DMT plasma concentrations peak at approximately 15–20 ng/mL within 1.5–2 hours. This plant is classified as a controlled substance in many jurisdictions due to its DMT content.

Preparation & Dosage

Chacruna is typically used in conjunction with Ayahuasca Vine in ceremonial brews. Dosage is determined by a shaman. Consult a healthcare provider before use.

Synergy & Pairings

Banisteriopsis caapi, Diplopterys cabrerana, Ayahuasca Vine, Tobacco

Safety & Interactions

DMT can cause intense psychological effects, nausea, increased heart rate, and blood pressure elevation during acute phases. Contraindicated with MAO inhibitors, SSRIs, and other serotonergic medications due to serotonin syndrome risk. Not recommended during pregnancy, breastfeeding, or for individuals with cardiovascular conditions, psychotic disorders, or severe mental health conditions. Legal status varies significantly by jurisdiction, with most countries classifying DMT as a controlled substance.